Medtronic, Inc. (MDT) Tops Q2 EPS by 2c; Reaffirms Outlook
Tweet
Share
E-mailGet Alerts MDT Hot Sheet
Price: $93.35 +1.14%
Revenue Growth %: +11.0%
Financial Fact:
Cost of products sold: 1.13B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Revenue Growth %: +11.0%
Financial Fact:
Cost of products sold: 1.13B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Medtronic, Inc. (NYSE: MDT) reported Q2 EPS of $0.84, $0.02 better than the analyst estimate of $0.82. Revenue for the quarter came in at $4.13 billion versus the consensus estimate of $4.07 billion.
Medtronic, Inc. reaffirmed FY2011 guidance.
Medtronic, Inc. reaffirmed FY2011 guidance.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Piper Sandler: PFA survey is most positive for Medtronic, Inc. (MDT)
- TJX Cos. (TJX) Tops Q2 EPS by 3c, Beats on Revenue; Offers FY27 EPS Guidance
- Opera Limited (OPRA) Misses Q2 EPS by 1c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
